Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Strides Pharma Science Ltd - 532531 - Board to consider FY20 Results & Dividend on May 20, 2020

 Strides Pharma Science Ltd has informed BSE that a meeting of Board of Directors of the Company is scheduled to be held on May 20, 2020 to consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31, 2020 and recommendation of dividend, if any, amongst other matters.Further, as per the provisions of the Company's Code for Prevention of Insider Trading, trading window for designated persons of the Company is already closed from April 01, 2020 till May 22, 2019 (both days inclusive).
11-05-2020
Bigul

Strides Pharma Science Ltd - 532531 - Board Meeting Intimation for Announcement Of Board Meeting

 Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2020 ,inter alia, to consider and approve We write to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday, May 20, 2020 to consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31, 2020 and recommendation of dividend, if any, amongst other matters. Further, as per the provisions of the Company's Code for Prevention of Insider Trading, trading window for designated persons of the Company is already closed from Wednesday, April 1, 2020 till Friday, May 22, 2019 (both days inclusive). This is for your kind information and record purposes.
11-05-2020
Bigul

Strides Pharma Science Ltd - 532531 - Certificate Pursuant To Regulation 40 (9) Of SEBI (LODR) Regulations, 2015.

 Pursuant to Regulation 40 (9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the Compliance Certificate for the half year ended on March 31, 2020 duly certified by the Practicing Company Secretary. Request you to kindly take the same on record.
06-05-2020
Bigul

Strides Pharma Science Ltd - 532531 - Statement Of Investor Complaints For The Quarter Ended March 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 033330 Name of the Signatory :- Manjula RamamurthyDesignation :- Company Secretary and Compliance Officer
06-05-2020
Bigul

Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 30, 2020 for Pronomz Ventures LLP and Agnus Holdings Pvt Ltd
30-04-2020
Bigul

Strides Pharma Soars 10% On Development Of Antivirals For Covid-19

 Strides Pharma shares zoomed more than 10 per cent on the BSE on Thursday after the company said that it has developedFavipiravir antiviral tablets for the treatment of COVID-19.
30-04-2020
Bigul

Strides, Voda shine, financials party; 90 scrips at 52-week lows

 Here are the key trends captured from Wednesday's session.
29-04-2020
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Strides develops and commences export of Favipiravir Antiviral Tablets
29-04-2020
Bigul

Strides Pharma Science Ltd - 532531 - Compliance Certificate - For The Half - Year Ended 31.03.2020 Ref: Regulation 7(3) Of SEBI (LODR) Regulations, 2015

 As per the requirement of Regulation 7(3) of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015, we hereby confirm that the activities in relation to both physical and electronic share transfer facility for the period from October 1, 2019 to March 31, 2020 are maintained with the Company's Registrar and Share Transfer Agent, M/s. KFin Technologies Private Limited (Formerly, Karvy Fintech Private Limited), Hyderabad who are registered with SEBI vide registration number INR000000221.
27-04-2020
Bigul

Strides Pharma Science Ltd - 532531 - Shareholding for the Period Ended March 31, 2020

 Strides Pharma Science Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here
20-04-2020
Next Page
Close

Let's Open Free Demat Account